Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pace of Designer Drugs Increases Year on Year

Published: Monday, August 12, 2013
Last Updated: Monday, August 12, 2013
Bookmark and Share
Science needs to work hard to keep pace with clandestine designer drugs labs – that was the hard-hitting message delivered to delegates at AACC Clinical Lab Expo.

Leading testing firm, Randox Toxicology highlighted the problem and outlined the requirement for a rapid and comprehensive designer drugs testing system to tackle the issue. In recent years there has been a significant increase in new ‘designer drugs,’ also known as legal highs or bath salts. UN Drugs and Crime Office reported recently that member states have experienced a rise in numbers by more than 50 per cent in less than three years to 251 new designer drugs by mid-2012.

Speaking after addressing delegates, Randox Toxicology’s R&D team leader Dr Joanne Darragh said, “The current most prolific designer substances are synthetic cannabinoids (K2 and SPICE) and the synthetic cathinones, commonly referred to as ‘Bath Salts’ mirroring to a large extent the effects of the most popular traditional drugs. A recent development, however, is an increasing proportion of substances reported that are from less known and more obscure chemical groups. These compounds are often not detected among users who undergo regular drug screening due to the absence of a wider screening methodology.”

Randox Toxicology have developed the most rapid and comprehensive designer drug test in the world, as Dr Darragh further explained,

“Randox’s unique multiplex system allows us to detect 110 designer drugs, from one blood or urine sample.

“There is also a growing trend coming from the labs creating designer drugs to modify the molecular structure in order to navigate national and international bans. Development of new antibodies means that Randox Toxicology have the capability to rapidly meet changing trends in designer drug use, in fact, we can adapt our technology to test for new or modified drugs quicker than any other supplier in the world.”

“Thanks to Randox’s revolutionary biochip array technology, we can adapt any test in a completely unique and accurate way to produce the quickest result.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Ketamine Metabolism Lifts Depression
NIH-funded team finds rapid-acting, non-addicting agent in mouse study.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!